Avantor, Inc. (NYSE:AVTR) Shares Sold by Franklin Resources Inc.

Franklin Resources Inc. trimmed its stake in Avantor, Inc. (NYSE:AVTRGet Rating) by 6.6% during the second quarter, HoldingsChannel.com reports. The fund owned 3,605,097 shares of the company’s stock after selling 254,214 shares during the period. Franklin Resources Inc.’s holdings in Avantor were worth $112,119,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in shares of Avantor by 22.0% in the 2nd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 38,823 shares of the company’s stock worth $1,207,000 after acquiring an additional 7,013 shares during the last quarter. Dynamic Advisor Solutions LLC acquired a new stake in shares of Avantor in the second quarter worth $387,000. OLD National Bancorp IN boosted its position in shares of Avantor by 3.1% in the second quarter. OLD National Bancorp IN now owns 21,947 shares of the company’s stock worth $683,000 after buying an additional 670 shares during the period. Swiss National Bank boosted its position in shares of Avantor by 11.4% in the second quarter. Swiss National Bank now owns 2,645,883 shares of the company’s stock worth $82,287,000 after buying an additional 270,100 shares during the period. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its position in shares of Avantor by 6.7% in the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 135,979 shares of the company’s stock worth $4,599,000 after buying an additional 8,564 shares during the period. 81.22% of the stock is currently owned by institutional investors and hedge funds.

Avantor Price Performance

Shares of NYSE:AVTR opened at $21.53 on Thursday. Avantor, Inc. has a fifty-two week low of $17.91 and a fifty-two week high of $42.48. The business has a 50-day moving average of $20.54 and a two-hundred day moving average of $26.30. The stock has a market capitalization of $14.52 billion, a P/E ratio of 22.90 and a beta of 1.37. The company has a debt-to-equity ratio of 1.29, a current ratio of 1.65 and a quick ratio of 1.07.

Avantor (NYSE:AVTRGet Rating) last announced its quarterly earnings results on Friday, October 28th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.01. Avantor had a return on equity of 24.67% and a net margin of 8.38%. The company had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.85 billion. During the same quarter in the previous year, the firm earned $0.35 earnings per share. The business’s quarterly revenue was up 1.2% compared to the same quarter last year. On average, equities research analysts predict that Avantor, Inc. will post 1.39 EPS for the current fiscal year.

Analyst Ratings Changes

AVTR has been the subject of several recent analyst reports. Evercore ISI decreased their target price on Avantor to $35.00 in a research report on Tuesday, August 9th. Credit Suisse Group decreased their target price on Avantor from $32.00 to $25.00 and set a “neutral” rating for the company in a research report on Monday, October 31st. Robert W. Baird reduced their price objective on Avantor from $32.00 to $29.00 and set an “outperform” rating for the company in a research report on Monday, October 31st. UBS Group reduced their price objective on Avantor to $33.00 in a research report on Friday, November 4th. Finally, Wells Fargo & Company reduced their price objective on Avantor from $33.00 to $27.00 and set an “overweight” rating for the company in a research report on Monday, October 31st. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $28.93.

Insiders Place Their Bets

In other Avantor news, CEO Michael Stubblefield acquired 15,000 shares of the company’s stock in a transaction dated Wednesday, November 16th. The shares were acquired at an average cost of $20.95 per share, for a total transaction of $314,250.00. Following the completion of the purchase, the chief executive officer now owns 429,500 shares of the company’s stock, valued at approximately $8,998,025. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Avantor news, CEO Michael Stubblefield acquired 15,000 shares of the company’s stock in a transaction dated Wednesday, November 16th. The shares were acquired at an average cost of $20.95 per share, for a total transaction of $314,250.00. Following the completion of the purchase, the chief executive officer now owns 429,500 shares of the company’s stock, valued at approximately $8,998,025. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Thomas A. Szlosek acquired 12,500 shares of the company’s stock in a transaction dated Wednesday, November 16th. The stock was acquired at an average price of $20.71 per share, for a total transaction of $258,875.00. Following the completion of the purchase, the chief financial officer now directly owns 35,668 shares of the company’s stock, valued at approximately $738,684.28. The disclosure for this purchase can be found here. Insiders own 1.60% of the company’s stock.

About Avantor

(Get Rating)

Avantor, Inc provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Stories

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRGet Rating).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.